Patents by Inventor Artur Kochoyan

Artur Kochoyan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibroblast Growth Factor Receptor-Derived Peptides Binding to NCAM
    Publication number: 20140234294
    Abstract: The present invention relates to the use of peptides that are capable of binding to, and modulating the activity of NCAM. The peptides are peptide fragments of FGFRs. They are derived from two distinct binding sites for binding of the immunoglobulin-like module 2 of FGFR to NCAM F3 modules 1-2. The invention further relates to use of said peptides for the production of a medicament for the treatment of different pathological conditions, wherein NCAM and/or FGFRs play a prominent role.
    Type: Application
    Filed: December 24, 2013
    Publication date: August 21, 2014
    Applicant: Kobenhavns Universitet
    Inventors: Vladimir Berezin, Elisabeth Bock, Artur Kochoyan
  • Fibroblast growth factor receptor-derived peptides binding to NCAM
    Patent number: 8637465
    Abstract: The present invention relates to the use of peptides that are capable of binding to, and modulating the activity of NCAM. The peptides are peptide fragments of FGFRs. They are derived from two distinct binding sites for binding of the immunoglobulin-like module 2 of FGFR to NCAM F3 modules 1-2. The invention further relates to use of said peptides for the production of a medicament for the treatment of different pathological conditions, wherein NCAM and/or FGFRs play a prominent role.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: January 28, 2014
    Assignee: Kobenhavns Universitet
    Inventors: Vladimir Berezin, Elisabeth Bock, Artur Kochoyan
  • FIBROBLAST GROWTH FACTOR RECEPTOR-DERIVED PEPTIDES BINDING TO NCAM
    Publication number: 20120141451
    Abstract: The present invention relates to the use of peptides that are capable of binding to, and modulating the activity of NCAM. The peptides are peptide fragments of FGFRs. They are derived from two distinct binding sites for binding of the immunoglobulin-like module 2 of FGFR to NCAM F3 modules 1-2. The invention further relates to use of said peptides for the production of a medicament for the treatment of different pathological conditions, wherein NCAM and/or FGFRs play a prominent role.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 7, 2012
    Inventors: Vladimir Berezin, Elisabeth Bock, Artur Kochoyan